Cell Cycle Effects of Iniparib, a PARP Inhibitor, in Combination with Gemcitabine and Carboplatin in the MDA-MB-468(-) Triple-Negative Breast Cancer (TNBC) Cell Line

被引：0
|
作者：
Ossovskaya, V.
Lim, C-U
Schools, G.
Kalurupalle, S.
Roninson, I. B.
Broude, E.
机构：
[1] BiPar Sci Inc, San Francisco, CA USA
[2] Ctr Canc, Ordway Res Inst, Albany, NY USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1156/0006-5472.SABCS10-P5-06-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-06-09
引用
收藏
页数：1
相关论文
共 50 条
  • [21] KNOCKDOWN OF TRIM66 IN MDA-MB-468 TRIPLE NEGATIVE BREAST CANCER CELL LINE SUPPRESSES PROLIFERATION AND PROMOTES APOPTOSIS THROUGH EGFR SIGNALING
    Zhang, Huayi
    Zheng, Yaqin
    Zhang, Yongmei
    POLISH JOURNAL OF PATHOLOGY, 2021, 72 (02) : 160 - 166
  • [22] Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line
    Kumari, Seema
    Mohan, Murali G.
    Shailender, G.
    Badana, Anil Kumar
    Malla, Rama Rao
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (10) : 18104 - 18116
  • [23] Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells
    Balabhadrapathruni, S
    Thomas, TJ
    Yurkow, EJ
    Amenta, PS
    Thomas, T
    ONCOLOGY REPORTS, 2000, 7 (01) : 3 - 12
  • [24] FINAL EFFICACY AND SAFETY RESULTS OF A RANDOMIZED PHASE II STUDY OF THE PARP INHIBITOR INIPARIB (BSI-201) IN COMBINATION WITH GEMCITABINE/CARBOPLATIN (G/C) IN METASTATIC TRIPLE NEGATIVE BREAST CANCER (TNBC)
    O'Shaughnessy, J.
    Osborne, C.
    Pippen, J.
    Yoffe, M.
    Patt, D.
    Monaghan, G.
    Rocha, C.
    Sherman, B. M.
    Bradley, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 5 - 5
  • [25] PRIMA-1MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
    Kotob, Shadi N.
    Kelts, Jessica L.
    ACS OMEGA, 2023, 8 (33): : 30500 - 30507
  • [26] Effects of Urtica dioica dichloromethane extract on cell apoptosis and related gene expression in human breast cancer cell line (MDA-MB-468)
    Mohammadi, A.
    Mansoori, B.
    Goldar, S.
    Shanehbandi, D.
    Khaze, V.
    Mohammadnejad, L.
    Baghbani, E.
    Baradaran, B.
    CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (02) : 62 - 67
  • [27] Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer
    Liang, Hongyan
    Tan, Antoinette R.
    IDRUGS, 2010, 13 (09) : 646 - 656
  • [28] Pre-clinical combination of a PARP inhibitor, talazoparib, and carboplatin in triple-negative breast cancer.
    Cotte, Alexia
    Beniey, Michele
    Haque, Takrima
    Bechir, Nelly
    Hubert, Audrey
    Diallo, Korotoum W.
    Tran-Thanh, Danh
    Hassan, Saima N.
    CANCER RESEARCH, 2021, 81 (13)
  • [29] Characterization of PARP inhibitor combination therapies in triple-negative breast cancer
    Fyle, Elicia
    Abdesselam, Djihane
    Frederick, Mallory
    Hassan, Saima N.
    CANCER RESEARCH, 2024, 84 (06)
  • [30] The effect of the garlic organosulfide diallyl trisulfide (DATS) on TNF-alpha induced cell proliferation in the MDA MB-231 and MDA MB-468 triple-negative breast cancer cell line
    Kanga, Konan
    Darling-Reed, Selina
    Tilghman, Syreeta
    Flores-Rozas, Hernan
    Latinwo, Lekan
    Bauer, David
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 37 - 37
12345